ProCE Banner Activity

How I Am Managing Patients With Advanced Breast Cancer During the COVID-19 Pandemic

Case Challenge
Clinical Thought
As the COVID-19 pandemic continues to affect daily practice, how can we ensure continuity and safety in the care of our patients with advanced breast cancer? Here’s my take.

Released: September 25, 2020

Expiration: September 24, 2021

Share

Faculty

Hope S. Rugo

Hope S. Rugo, MD

Clinical Professor of Medicine
UCSF Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Daiichi Sankyo, Inc.

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Hope S. Rugo, MD

Clinical Professor of Medicine
UCSF Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

Hope S. Rugo, MD, has disclosed that she has received funds for research support from Daiichi Sankyo, Eisai, Genentech, Immunomedics, Lilly, Macrogenics, Merck, Novartis, OBI, Odonate, Pfizer, Seattle Genetics, and Sermonix; consulting fees from Puma and Samsung; and funds for non-CME services from AstraZeneca, Daiichi Sankyo, Macrogenics, Merck, Mylan, Novartis, and Pfizer.

Additional Information

Program Medium

This program has been made available online.